Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-20

Clinical Trial Update: A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating HR18034 for postoperative analgesia in hemorrhoidectomy patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HR18034

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Postsurgical Pain Management | Phase 2 | Status: COMPLETED